Back to search

Biological rationale for HER2/neu (c-erbB2) as a target for monoclonal antibody therapy.

M. Pegram, DJ Slamon
PubMed

Data up to Jan 2025

Published2000
Citations147
References0
Fields
MedicineBiologyCancer researchImmunologyCell biology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Biological rationale for HER2/neu (c-erbB2) as a target for monoclonal antibody therapy. (2000) – PubMed | Metascience Observatory Explorer